Literature DB >> 20185923

Penicillin allergy: value of including amoxicillin as a determinant in penicillin skin testing.

Erina Lin1, Andrew Saxon, Marc Riedl.   

Abstract

BACKGROUND: Allergy to penicillins remains an important issue. Penicillin skin testing (PST) with major and minor determinants has been shown to be a highly valuable tool for identifying IgE-mediated penicillin allergy. The value of additional testing with side-chain-specific moieties from semisynthetic penicillins such as amoxicillin is not well-established in spite of the widespread use of these medications.
METHODS: A retrospective review of all consecutive inpatient PST results from 1995 to 2007 comprising 1,068 patients was performed in our institution on individuals with a self-reported history of beta-lactam allergy to assess the importance of including the amoxicillin determinant in a previously validated PST panel. Descriptive statistics were performed. The PST panel included penicilloyl-polylysine, penicillin G, penicilloate, penilloate and amoxicillin.
RESULTS: Of 1,068 patients, 243 (23%) had a positive skin test reaction on the PST panel. Testing with amoxicillin was positive in 30.9% of patients, the majority of whom (81%) were also positive to 1 or more standard penicillin reagents. Fourteen of the 243 positive patients (5.8%) had a positive skin test reaction only to amoxicillin. Additionally, the use of penicilloate and penilloate minor determinants in combination with penicillin G identified a greater percentage of penicillin-allergic individuals compared to using only penicillin G (22.6 vs. 6.6%), demonstrating their importance in the PST panel.
CONCLUSIONS: These data indicate that the inclusion of the amoxicillin determinant appears to identify a small but important group of allergic individuals who may otherwise test negative on a PST panel. Copyright 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20185923     DOI: 10.1159/000288284

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  8 in total

Review 1.  Antimicrobial stewardship's new weapon? A review of antibiotic allergy and pathways to 'de-labeling'.

Authors:  Jason Trubiano; Elizabeth Phillips
Journal:  Curr Opin Infect Dis       Date:  2013-12       Impact factor: 4.915

Review 2.  Evaluation of antibiotic allergy: the role of skin tests and drug challenges.

Authors:  Roland Solensky; David A Khan
Journal:  Curr Allergy Asthma Rep       Date:  2014-09       Impact factor: 4.806

Review 3.  Penicillin and beta-lactam allergy: epidemiology and diagnosis.

Authors:  Eric Macy
Journal:  Curr Allergy Asthma Rep       Date:  2014-11       Impact factor: 4.806

4.  Adverse reactions associated with therapeutic antibiotic use after penicillin skin testing.

Authors:  Eric Macy; Ngoc J Ho
Journal:  Perm J       Date:  2011

Review 5.  Recommendations for the management of beta-lactam intolerance.

Authors:  Eric Macy; Eunis Ngor
Journal:  Clin Rev Allergy Immunol       Date:  2014-08       Impact factor: 10.817

6.  Implementation of an Infectious Disease Fellow-Managed Penicillin Allergy Skin Testing Service.

Authors:  Emily L Heil; Jacqueline T Bork; Sarah A Schmalzle; Michael Kleinberg; Anupama Kewalramani; Bruce L Gilliam; Ulrike K Buchwald
Journal:  Open Forum Infect Dis       Date:  2016-07-23       Impact factor: 3.835

Review 7.  Anaphylaxis in the 21st century: phenotypes, endotypes, and biomarkers.

Authors:  Teodorikez Wilfox Jimenez-Rodriguez; Marlene Garcia-Neuer; Leila A Alenazy; Mariana Castells
Journal:  J Asthma Allergy       Date:  2018-06-20

8.  A retrospective comparison of false negative skin test rates in penicillin allergy, using pencilloyl-poly-lysine and minor determinants or Penicillin G, followed by open challenge.

Authors:  Lana Rosenfield; Chrystyna Kalicinsky; Richard Warrington
Journal:  Allergy Asthma Clin Immunol       Date:  2015-11-20       Impact factor: 3.406

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.